Hartley Medical Center Pharmacy Recalls Morphine Sulfate Syringes Due to Sterility Concerns
Hartley Medical Center Pharmacy is recalling two syringes of Morphine Sulfate 1.5 mg/ml due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly when involving potential hospitalization or significant injury risks associated with sterility failures in injectable drugs.
Plain-English summary
Hartley Medical Center Pharmacy, Incorporated is recalling two syringes of Morphine Sulfate 1.5 mg/ml, 20 ml volume, prescription only. The recall is being conducted because of a lack of assurance of sterility for the product.
The affected product has a beyond-use date of May 3, 2016. The recall is limited to the United States, with no foreign distribution reported.
Consumers and healthcare providers should stop using the recalled syringes and contact the recalling firm or their healthcare provider for further instructions.
The recalled product
- Product
- Morphine Sulfate 1.5 mg/ml, vol. 20 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA
- Manufacturer
- Hartley Medical Center Pharmacy, Incorporated
- Category
- Drug — Injectable
- Hazard
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- BUD: 5/3/2016
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 30 recalled by Hartley Medical Center Pharmacy, Incorporated under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Hartley Medical Center Pharmacy, Incorporated
See all →- SevereHartley Medical Center Pharmacy Recalls Sufentanil Citrate Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-03-16
- SevereHartley Medical Center Pharmacy Recalls Baclofen Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-03-16
- SevereHartley Medical Center Pharmacy Recalls Baclofen Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-03-16
- SevereMorphine Sulfate Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2016-03-16
- SevereHartley Medical Center Pharmacy Recalls Morphine and Bupivacaine Syringes
FDA (Drugs) · 2016-03-16
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereSCA Pharmaceuticals Recalls Morphine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2018-07-11
- SeverePharmakon Recalls Morphine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereAdvanced Pharma Recalls Morphine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-03-27
- HighMorphine Sulfate Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2022-07-27
- SeverePharmedium Recalls Morphine Sulfate Syringes Due to Stability Data Concerns
FDA (Drugs) · 2016-10-19
- HighMartin Avenue Pharmacy Recalls Morphine Sulfate Syringes for Sterility Concerns
FDA (Drugs) · 2014-11-05